Bone density scan (DEXA)
The use of dual-energy X-ray absorptiometry (DEXA) to measure bone mineral density (BMD) is widespread in humans and has been adapted to animals.
For preclinical research, DEXA can be applied to address a broad variety of drug development questions, e.g., monitoring BMD changes after administration of the API.